AGI Therapeutics, Aravis Therapeutics deal

AGI said shareholders had tendered 54 million shares (80.2%) under Aravis' offer to acquire AGI for €10.7 million ($14 million). The offer remains open until Feb. 17 (see BioCentury, Jan. 16). ...